Skip to main content
. Author manuscript; available in PMC: 2023 Dec 11.
Published in final edited form as: Hum Mutat. 2023 Mar 29;2023:9537832. doi: 10.1155/2023/9537832

Table 2.

DICER1 syndrome phenotypes grouped by specificity. For use with the following evidence codes: PS4, PS2, PP1, PP4, BS4.

Specificity Phenotypes
High-specificity
(much more likely than not to have germline P/LP DICER1)
Pleuropulmonary blastoma (PPB) (Including Type 1r)
Pituitary blastoma
Anaplastic renal sarcoma
Ciliary body medulloepithelioma
Cystic nephroma (<18 yrs)
Embryonal rhabdomyosarcoma (Ovarian)
Embryonal rhabdomyosarcoma (Cervix)
Moderate-specificity
(more likely than not to have germline P/LP DICER1)
Differentiated thyroid cancer and/or Multinodular goiter (<18 years)
Nasal chondromesenchymal hamartoma
Ovarian Sertoli-Leydig cell tumors
Ovarian sex-cord stromal tumor of mixed type (specifically, gynandroblastoma)
Low-specificity
(less likely to have DICER1)
Non-parasitic liver cysts (childhood) Wilms tumor
Pineoblastoma
Cerebral sarcoma Lung cysts (<18 yrs)
**For PP4 use ONLY** Additional neoplasms of very low or undetermined specificity Thyroid neoplasms (any age)
Sarcomas
Juvenile hamartomatous polyps
Primitive neuroectodermal/neuroepithelial neoplasms
Infantile cerebellar embryonal tumors
Fetal lung adenocarcinoma